FDG-PET/CT与调强放疗时代下的原发灶不明头颈鳞癌
荷兰癌症研究所2006至2016年回顾性分析80例经PET分期并接受根治性调强放疗的头颈部原发灶不明癌患者。黏膜照射患者局部控制率100%,区域控制率90%,5年总生存62%、疾病特异生存78%。包膜外侵犯、N3、多区域阳性淋巴结及下颈阳性淋巴结与预后不良相关。
要点
- 黏膜照射患者局部控制率100%,区域控制率90%。
- 5年总生存62%,疾病特异生存78%。
- 包膜外侵犯、N3、多区域及下颈阳性淋巴结与预后不良相关。
核心结论
- 采用现代技术治疗的头颈部原发灶不明癌局部区域结局良好,未来研究需关注减少毒性和筛选远处转移高危患者。
研究设计与样本
- 荷兰癌症研究所2006至2016年回顾性分析80例经PET分期并接受根治性调强放疗的头颈部原发灶不明癌患者,记录患者、肿瘤及治疗资料并分析肿瘤学结局。
主要发现
- 黏膜照射患者局部控制率为100%,区域控制率为90%。
- 10例患者出现远处转移,与N3、包膜外侵犯及下颈阳性淋巴结相关。
- 5年总生存率为62%,疾病特异生存率为78%。
- 包膜外侵犯、N3颈部、多区域阳性淋巴结及下颈阳性淋巴结与更差预后相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The diagnosis and treatment of head and neck carcinoma of unknown primary (CUP) have changed with the introduction of fluorodeoxyglucose-positron emission tomography (FDG-PET)/CT and intensity-modulated radiotherapy (IMRT), with potential implications for outcome. METHODS: We conducted a retrospective analysis of 80 patients with head and neck CUP who were PET-staged and treated with curative intention using IMRT between 2006 and 2016 in the Netherlands Cancer Institute. Patient, tumor, and treatment demographics were recorded and oncologic outcomes were analyzed. RESULTS: Local control was 100% in mucosal irradiated patients. Regional control was 90%. Ten patients developed distant metastases, which were associated with N3, extracapsular extension (ECE) and lower neck positive lymph nodes. Overall survival (OS) at 5 years was 62% and disease-specific survival was 78%. ECE, N3 neck, multiple levels of positive lymph nodes, and positive lymph nodes in the lower neck were associated with worse prognosis. CONCLUSION: Locoregional outcome of head and neck CUP managed with modern techniques is good. Future research needs to focus on reducing toxicity and patients prone for distant metastasis.
引用
- de Ridder M, Klop M, Hamming-Vrieze O, et al. Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy. Head Neck. 2017. PMID: 28370570. doi:10.1002/hed.24762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。